A Republican bill with 39 Democratic cosponsors · See all 61 cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill is known as the John W. Walsh Alpha-1 Home Infusion Act of 2025. It amends the Social Security Act to provide Medicare coverage and payment for Alpha-1 Antitrypsin Deficiency Disorder treatment under part B. The treatment involves augmentation therapy furnished by qualified home infusion therapy suppliers directly in an individual's home. To qualify, individuals must be under the care of an applicable provider and enrolled in both parts A and B of Medicare while not being enrolled in a part C Medicare Advantage plan. The legislation also sets up a payment system for intravenous administration kits and up to two hours of nursing services. These changes are scheduled to apply to items and services furnished on or after January 1, 2027.
Yes· 3 of 5
- Scored +8
Does this make health care easier to get in general?
The bill improves access to essential augmentation therapy through home-based infusion services.
- Scored +7
Would people over 65 be better off under this?
The bill provides crucial Medicare coverage for chronic disease management, which primarily benefits seniors.
- Scored +7
Would retired people be better off under this?
The expansion of Medicare Part B benefits directly supports the health needs of retirees.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Section 2(a) adds Alpha-1 Antitrypsin Deficiency Disorder treatment to Medicare part B coverage. This is positive because it helps individuals receive coverage for necessary augmentation therapy in their own homes if they are under the care of an applicable provider and enrolled in parts A and B without a part C Medicare Advantage plan.
-
Section 2(b) establishes a payment system for intravenous administration kits and nursing services for up to two hours of care. This is positive because it helps cover the supplies and nursing care needed when patients receive their treatments at home.
Potential Negative Impacts for People
- Section 2(a) specifies that individuals must not be enrolled in an MA plan under part C to qualify for this home infusion treatment coverage. This is a potential burden or negative for people because those who have chosen a part C Medicare Advantage plan are excluded from this specific coverage pathway.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would retired people be better off under this? — The expansion of Medicare Part B benefits directly supports the health needs of retirees. Would people over 65 be better off under this? — The bill provides crucial Medicare coverage for chronic disease management, which primarily benefits seniors. Would people with disabilities be better off under this? — The bill assists individuals with chronic health deficiencies by covering essential home-based treatment.
- Healthcare
- Does this make health care easier to get in general? — The bill improves access to essential augmentation therapy through home-based infusion services. Does this put more money into Medicare, the health coverage for people over 65? — The bill expands Medicare Part B coverage to include specific treatments for Alpha-1 deficiency.
- 10/22/2026
- 1 Cosponsor added.
- 10/1/2026
- 1 Cosponsor added.
- 9/24/2026
- 3 Cosponsors added.
- 9/16/2026
- 1 Cosponsor added.
- 7/20/2026
- 1 Cosponsor added.
- 6/2/2026
- 1 Cosponsor added.
- 5/14/2026
- 1 Cosponsor added.
- 4/30/2026
- 1 Cosponsor added.
- 4/23/2026
- 1 Cosponsor added.
- 4/21/2026
- 1 Cosponsor added.
- 3/24/2026
- 2 Cosponsors added.
- 2/12/2026
- 1 Cosponsor added.
- 12/18/2025
- 2 Cosponsors added.
- 12/15/2025
- 2 Cosponsors added.
- 12/5/2025
- 1 Cosponsor added.
- 11/12/2025
- 1 Cosponsor added.
- 11/7/2025
- 1 Cosponsor added.
- 11/4/2025
- 1 Cosponsor added.
- 10/24/2025
- 2 Cosponsors added.
- 10/21/2025
- 1 Cosponsor added.
- 10/17/2025
- 1 Cosponsor added.
- 10/14/2025
- 1 Cosponsor added.
- 10/8/2025
- 2 Cosponsors added.
- 10/3/2025
- 1 Cosponsor added.
- 9/19/2025
- 4 Cosponsors added.
- 9/9/2025
- 1 Cosponsor added.
- 9/4/2025
- 1 Cosponsor added.
- 8/8/2025
- 2 Cosponsors added.
- 8/1/2025
- 2 Cosponsors added.
- 7/29/2025
- 4 Cosponsors added.
- 6/30/2025
- 2 Cosponsors added.
- 6/10/2025
- 1 Cosponsor added.
- 6/5/2025
- 4 Cosponsors added.
- 5/29/2025
- 1 Cosponsor added.
- 3/25/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 8 Cosponsors added.
- Introduced in House
Ami BeraDemocrat · California
Don BaconRepublican · Nebraska
Janelle BynumDemocrat · Oregon
Angie CraigDemocrat · Minnesota
Troy CarterDemocrat · Louisiana
Herbert ConawayDemocrat · New Jersey
Christopher DeluzioDemocrat · Pennsylvania
Sarah ElfrethDemocrat · Maryland
Mike FloodRepublican · Nebraska
John GaramendiDemocrat · California
Josh GottheimerDemocrat · New Jersey
Andrew GarbarinoRepublican · New York
Laura GillenDemocrat · New York
Mike HaridopolosRepublican · Florida
Henry JohnsonDemocrat · Georgia
Jonathan JacksonDemocrat · Illinois
William KeatingDemocrat · Massachusetts
Young KimRepublican · California
Thomas KeanRepublican · New Jersey
Timothy KennedyDemocrat · New York
Mike KennedyRepublican · Utah
John LarsonDemocrat · Connecticut
Stephen LynchDemocrat · Massachusetts
Michael LawlerRepublican · New York
Nicholas LangworthyRepublican · New York
George LatimerDemocrat · New York
Nicole MalliotakisRepublican · New York
Doris MatsuiDemocrat · California
Grace MengDemocrat · New York
Carol MillerRepublican · West Virginia
Celeste MaloyRepublican · Utah
LaMonica McIverDemocrat · New Jersey
Ryan MackenzieRepublican · Pennsylvania
April McClain DelaneyDemocrat · Maryland
Sarah McBrideDemocrat · Delaware
Eleanor NortonDemocrat · District of Columbia
Joe NeguseDemocrat · Colorado
Burgess OwensRepublican · Utah
Chellie PingreeDemocrat · Maine
Jimmy PanettaDemocrat · California
Deborah RossDemocrat · North Carolina
Raul RuizDemocrat · California
David RouzerRepublican · North Carolina
John RutherfordRepublican · Florida
Josh RileyDemocrat · New York
Christopher SmithRepublican · New Jersey
Adrian SmithRepublican · Nebraska
Bradley SchneiderDemocrat · Illinois
Darren SotoDemocrat · Florida
Mikie SherrillDemocrat · New Jersey
Mike ThompsonDemocrat · California
Paul TonkoDemocrat · New York
Rashida TlaibDemocrat · Michigan
David ValadaoRepublican · California
Jefferson Van DrewRepublican · New Jersey
Derrick Van OrdenRepublican · Wisconsin
Eugene VindmanDemocrat · Virginia
Debbie Wasserman SchultzDemocrat · Florida
Frederica WilsonDemocrat · Florida
Randy WeberRepublican · Texas
Bonnie Watson ColemanDemocrat · New Jersey